BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/16/2016 9:05:00 AM | Browse: 803 | Download: 1001
Publication Name World Journal of Experimental Medicine
Manuscript ID 21879
Country/Territory Italy
2015-07-30 14:18
Peer-Review Started
2015-07-31 09:16
To Make the First Decision
2015-09-16 09:00
Return for Revision
2015-09-22 12:03
Second Decision
2015-12-23 16:39
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2016-01-07 16:46
Articles in Press
2016-01-07 16:46
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2016-01-28 08:48
Publish the Manuscript Online
2016-02-16 09:05
ISSN 2220-315x (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Allergy
Manuscript Type Review
Article Title Hepatocellular carcinoma: Where are we?
Manuscript Source Invited Manuscript
All Author List Roberto Mazzanti, Umberto Arena and Renato Tassi
Funding Agency and Grant Number
Funding Agency Grant Number
Fondazione Italiana per lo Studio del Fegato - Italian Liver Foundation
Corresponding author Roberto Mazzanti, MD, Professor, Department of Experimental and Clinical Medicine, School of Sciences of Human Health, University of Florence, Largo Brambilla 3, 50134 Firenze, Italy. roberto.mazzanti@unifi.it
Keywords Hepatocellular carcinoma; Treatment; Liver cancer; Epidemiology; Liver transplantation; Percutaneous ethanol injection; Chemoembolization; Chemotherapy; Radiofrequency ablation
Core Tip This review summarizes on the current state of the art of treatment of hepatocellular carcinoma (HCC). After a brief chapter on epidemiology, risk factors and biology of HCC, the review presents all possible therapeutic approaches for HCC, from the most effective such as liver transplantation to important but palliative treatments which can prolong patient survival such as different types of trans-artery-chemo-embolization and chemotherapy.
Publish Date 2016-02-16 09:05
Citation Mazzanti R, Arena U, Tassi R. Hepatocellular carcinoma: Where are we? World J Exp Med 2016; 6(1): 21-36
Url http://www.wjgnet.com/2220-315X/full/v6/i1/21.htm
DOI http://dx.doi.org/10.5493/wjem.v6.i1.21
Full Article (PDF) WJEM-6-21.pdf
Full Article (Word) WJEM-6-21.doc
Manuscript File 21879-Review.docx
Answering Reviewers 21879-Answering reviewers.pdf
Audio Core Tip 21879-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 21879-Conflict-of-interest statement.pdf
Copyright License Agreement 21879-Copyright assignment.pdf
Peer-review Report 21879-Peer-review(s).pdf
Scientific Misconduct Check 21879-Scientific misconduct check.pdf
Scientific Editor Work List 21879-Scientific editor work list.pdf